Cambios en el control glucémico antes y después de la cuarentena por la COVID-19

Javier R. Murillo-Valle; Juan L. Meza-Ponte

doi:10.17843/rpmesp.2023.403.12830

Authors

Javier R. Murillo-Valle Hospital Vitarte, Lima, Perú https://orcid.org/0000-0002-9575-4950
Juan L. Meza-Ponte Hospital Vitarte, Lima, Perú https://orcid.org/0009-0002-0500-1283

DOI:

https://doi.org/10.17843/rpmesp.2023.403.12830

Downloads

Download data is not yet available.

References

Dyer O. Covid-19: Pandemic is having “severe” impact on non-communicable disease care, WHO survey finds. BMJ. 2020 Jun 3;369:m2210. doi: 10.1136/bmj.m2210.

King P, Peacock I, Donnelly R. The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999 Nov;48(5):643-8. doi: 10.1046/j.1365-2125.1999.00092.x.

American Diabetes Association; Standards of Medical Care in Diabetes—2022 Abridged for Primary Care Providers. Clin Diabetes 1 January 2022; 40 (1): 10–38. doi: 10.2337/cd22-as01.

American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update. volume 29, issue 5, p305-340, may 2023: doi: 10.1016/j.eprac.2023.02.001.

Alonso N, Batule S. COVID-19 y diabetes mellitus. Importancia del control glucémico. COVID-19 y diabetes mellitus. Importancia del control glucemico. Clin Investig Arterioscler . 2021;33(3):148-150. doi: 10.1016/j.arteri.2021.05.001.

Tannus LRM, Zapelini RM, Cabizuca CA, Abi-Abib RC, Matheus ASM, Calassara PC, et al. Effect of the COVID-19 pandemic on glycemic control in Brazilian patients with type 2 diabetes. Endocrine. 2022 Sep;77(3):455-460. doi: 10.1007/s12020-022-03137-1.

Psoma O, Papachristoforou E, Kountouri A, Balampanis K, Stergiou A, Lambadiari V, et al. Effect of COVID-19-associated lockdown on the metabolic control of patients with type 2 diabetes. J Diabetes Complications. 2020 Dec;34(12):107756. doi: 10.1016/j.jdiacomp.2020.107756.

Tanji Y, Sawada S, Watanabe T, Mita T, Kobayashi Y, Murakami T, et al. Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: A hospital-based survey from a country without lockdown. Diabetes Res Clin Pract. 2021 Jun;176:108840. doi: 10.1016/j.diabres.2021.108840.

Ojo O, Wang X, Ojo OO, Orjih E, Pavithran N, Adegboye A et al. The Effects of COVID-19 Lockdown on Glycaemic Control and Lipid Profile in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 2022 Jan 19;19(3). 1095. doi: 10.3390/ijerph19031095.